Truist Financial Corp Alector, Inc. Transaction History

Truist Financial Corp

$65.3 Billion
Q1 2024

A detailed history of Truist Financial Corp transactions in Alector, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 39,845 shares of ALEC stock, worth $172,927. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,845

Previous 45,638 12.69%

Holding current value

$172,927

Previous $364,000 34.34%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$5.69 - $8.08 $32,962 - $46,807	-5,793 Reduced 12.69%	39,845 $239,000
Q4 2023 Feb 02, 2024	SELL	$3.77 - $8.39 $15,268 - $33,979	-4,050 Reduced 8.15%	45,638 $364,000
Q3 2023 Nov 14, 2023	SELL	$5.2 - $8.77 $60,866 - $102,652	-11,705 Reduced 19.07%	49,688 $321,000
Q2 2023 Aug 01, 2023	BUY	$5.86 - $7.93 $43,991 - $59,530	7,507 Added 13.93%	61,393 $368,000
Q1 2023 May 05, 2023	BUY	$5.85 - $9.84 $31,543 - $53,057	5,392 Added 11.12%	53,886 $333,000

Q4 2022 Feb 17, 2023	SELL	$6.88 - $9.55 $13,656 - $18,956	-1,985 Reduced 3.93%	48,494 $447,000
Q3 2022 Oct 26, 2022	BUY	$8.19 - $13.2 $10,098 - $16,275	1,233 Added 2.5%	50,479 $477,000
Q2 2022 Jul 22, 2022	BUY	$7.65 - $14.24 $86,070 - $160,214	11,251 Added 29.61%	49,246 $500,000
Q1 2022 Apr 22, 2022	BUY	$13.02 - $20.78 $45,166 - $72,085	3,469 Added 10.05%	37,995 $541,000
Q4 2021 Feb 14, 2022	SELL	$19.35 - $25.54 $1,896 - $2,502	-98 Reduced 0.28%	34,526 $713,000
Q3 2021 Nov 05, 2021	BUY	$21.65 - $39.49 $245,034 - $446,947	11,318 Added 48.56%	34,624 $791,000
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $151,125 - $219,180	9,750 Added 71.92%	23,306 $485,000
Q1 2021 May 17, 2021	BUY	$14.84 - $22.23 $8,918 - $13,360	601 Added 4.64%	13,556 $273,000
Q4 2020 Feb 18, 2021	BUY	$9.4 - $16.7 $121,777 - $216,348	12,955 New	12,955 $196,000

Others Institutions Holding ALEC

# of Institutions

161

Shares Held

59.8M

Call Options Held

67.8K

Put Options Held

200

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $358M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Alector, Inc. Transaction History